The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
The Energy Landscapes and Motions of Proteins
Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991) · Science · doi:10.1126/science.1749933 · Cited by 3,250
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Allosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
De Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate
Katz, B., & Thesleff, S. (1957) · The Journal of Physiology · doi:10.1113/jphysiol.1957.sp005838 · Cited by 1,461
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
d -Serine is an endogenous ligand for the glycine site of the N -methyl- d -aspartate receptor
Mothet, J.-P., Parent, A. T., Wolosker, H., Brady, R. O., Linden, D. J., Ferris, C. D., Rogawski, M. A., & Snyder, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4926 · Cited by 1,137
General Conclusions: Teleonomic Mechanisms in Cellular Metabolism, Growth, and Differentiation
Monod, J., & Jacob, F. (1961) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1961.026.01.048 · Cited by 1,072
Conformational Substates in Proteins
Frauenfelder, H., Parak, F., & Young, R. D. (1988) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.17.060188.002315 · Cited by 993
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Self-citationPharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Colquhoun, D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702164 · Cited by 881
Cuatrecasas, P. (1974) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.43.070174.001125 · Cited by 639
The benzodiazepine binding site of GABAA receptors
Sigel, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01118-8 · Cited by 594
Interaction of Convulsive Ligands with Benzodiazepine Receptors
Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., & Petersen, E. N. (1982) · Science · doi:10.1126/science.6281892 · Cited by 547
Costa, T., & Herz, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7321 · Cited by 536
l -Amino acid sensing by the extracellular Ca 2+ -sensing receptor
Conigrave, A. D., Quinn, S. J., & Brown, E. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4814 · Cited by 502
Functional domains of GABAA receptors
Smith, G. B., & Olsen, R. W. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89009-4 · Cited by 489
The two-state model of receptor activation
Leff, P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88989-0 · Cited by 488
From ion currents to genomic analysis: Recent advances in GABAA receptor research
Rabow, L. E., Russek, S. J., & Farb, D. H. (1995) · Synapse · doi:10.1002/syn.890210302 · Cited by 475
GABAA receptor subtypes: dissecting their pharmacological functions
Rudolph, U., Crestani, F., & Möhler, H. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01646-1 · Cited by 471
Interaction at end-plate receptors between different choline derivatives
Castillo, J. D., & Katz, B. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0018 · Cited by 470
Albuquerque, E. X., Alkondon, M., Pereira, E. F. R., Castro, N. G., Schrattenholz, A., Barbosa, C. T. F., Bonfante-Cabarcas, R., Aracava, Y., Eisenberg, H. M., & Maelicke, A. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36503-6 · Cited by 445
Croonian lecture.—On immunity with special reference to cell life
Ehrlich, P. (1900) · Proceedings of the Royal Society of London · doi:10.1098/rspl.1899.0121 · Cited by 441
Allosteric Receptors after 30 Years
Changeux, J.-P., & Edelstein, S. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80616-9 · Cited by 431
On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholine
Karlin, A. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90011-2 · Cited by 428
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Ehlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Litschig, S., Gasparini, F., Rueegg, D., Stoehr, N., Flor, P. J., Vranesic, I., Prézeau, L., Pin, J.-P., Thomsen, C., & Kuhn, R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12169-4 · Cited by 344
Jacoby, D. B., Gleich, G. J., & Fryer, A. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116331 · Cited by 339
Modification of the binding properties of muscarinic receptors by gallamine.
Stockton, J. M., Birdsall, N. J., Burgen, A. S., & Hulme, E. C. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14327-7 · Cited by 328
Ivermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor
Krause, R. M., Buisson, B., Bertrand, S., Corringer, P.-J., Galzi, J.-L., Changeux, J.-P., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.283 · Cited by 320
The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential
Leeson, P. D., & Iversen, L. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00050a001 · Cited by 315
Subunit- and site-specific pharmacology of the NMDA receptor channel
Yamakura, T., & Shimoji, K. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00007-6 · Cited by 311
Pharmacologic analysis of drug-receptor interaction
Short, A. L. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)90240-6 · Cited by 290
The benzodiazepine binding site of GABAA receptors
Sigel, E., & Buhr, A. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90675-1 · Cited by 290
Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking
Devi, L. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01799-5 · Cited by 282
Pagano, A., Rüegg, D., Litschig, S., Stoehr, N., Stierlin, C., Heinrich, M., Floersheim, P., Prezèau, L., Carroll, F., Pin, J.-P., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006230200 · Cited by 271
Lazareno, S., & Birdsall, N. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10255-1 · Cited by 263
THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS
CLARK, A. L., & MITCHELSON, F. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb07708.x · Cited by 251
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
Bruns, R. F., & Fergus, J. H. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09591-4 · Cited by 244
Urwyler, S., Mosbacher, J., Lingenhoehl, K., Heid, J., Hofstetter, K., Froestl, W., Bettler, B., & Kaupmann, K. (2001) · PubMed · Cited by 239
Knoflach, F., Mutel, V., Jolidon, S., Kew, J. N. C., Malherbe, P., Vieira, E., Wichmann, J., & Kemp, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231358298 · Cited by 238
Schrattenholz, A., Pereira, E. F., Roth, U., Weber, K. H., Albuquerque, E. X., & Maelicke, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08675-4 · Cited by 226
Current Protocols in Pharmacology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471141755 · Cited by 225
Structural and functional aspects of G protein-coupled receptor oligomerization
Hébert, T. E., & Bouvier, M. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-1-1 · Cited by 223
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., & Pease, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908864199 · Cited by 219
Urwyler, S., Mosbacher, J., Lingenhoehl, K., Heid, J., Hofstetter, K., Froestl, W., Bettler, B., & Kaupmann, K. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.963 · Cited by 219
Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders
Gasior, M., Carter, R. B., & Witkin, J. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01318-8 · Cited by 218
Neurotransmitter-gated ion channels as unconventional allosteric proteins
Galzi, J.-L., & Changeux, J.-P. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90218-6 · Cited by 197
The Relation between Classical and Cooperative Models for Drug Action
Colquhoun, D. (1973) · Drug Receptors · doi:10.1007/978-1-349-00910-7_11 · Cited by 192
Novel allosteric antagonists shed light on mglu5 receptors and CNS disorders
Spooren, W. P. J. M., Gasparini, F., Salt, T. E., & Kuhn, R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01694-1 · Cited by 189
Hall, D. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12715-0 · Cited by 187
BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.
Carroll, F. Y., Stolle, A., Beart, P. M., Voerste, A., Brabet, I., Mauler, F., Joly, C., Antonicek, H., Bockaert, J., Müller, T., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.965 · Cited by 171
Ehlert, F. J. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14182-5 · Cited by 168
WREGGETT, K. A., & Léan, A. D. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15078-5 · Cited by 151
Croonian Lecture, 1906.—On nerve endings and on special excitable substances in cells
Langley, J. N. (1906) · Proceedings of the Royal Society of London Series B Containing Papers of a Biological Character · doi:10.1098/rspb.1906.0056 · Cited by 143
FROM GABAA RECEPTOR DIVERSITY EMERGES A UNIFIED VISION OF GABAergic INHIBITION
Costa, E. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.321 · Cited by 143
Benzodiazepines on trial: a research strategy for their rehabilitation
Costa, E., & Guidetti, A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10015-8 · Cited by 141
Matsui, H., Lazareno, S., & Birdsall, N. J. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08527-x · Cited by 136
Changeux, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90049-e · Cited by 135
General anaesthetic action at transmitter-gated inhibitory amino acid receptors
Belelli, D., Pistis, M., Peters, J. A., & Lambert, J. J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01405-4 · Cited by 132
Cox, M. A., Jenh, C., Gonsiorek, W., Fine, J. S., Narula, S. K., Zavodny, P. J., & Hipkin, R. W. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09238-1 · Cited by 129
Thomas, E. A., Carson, M. J., Neal, M. J., & Sutcliffe, J. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14115 · Cited by 125
Allosteric Activation of the Ca2+ Receptor Expressed in Xenopus laevis Oocytes by NPS 467 or NPS 568
Hammerland, L. G., Garrett, J. E., Hung, B. C. P., Levinthal, C., & Nemeth, E. F. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13280-4 · Cited by 123
Lazareno, S., Gharagozloo, P., Kuonen, D. R., Popham, A., & Birdsall, N. J. M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.573 · Cited by 121
ALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORS
Christopoulos, A., Lanzafame, A. A., & Mitchelson, F. J. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.t01-4-.x · Cited by 113
Self-citationFunctional domains of GABA, receptors
Olsen, R. W. (1995) · Cited by 112
Allosteric modulation of A2A adenosine receptors by amiloride analogues and sodium ions
Gao, Z., & IJzerman, A. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00360-9 · Cited by 106
Proška, J., & Tucek, S. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10157-0 · Cited by 106
An allosteric model for benzodiazepine receptor function
Ehlert, F. J., Roeske, W. R., Gee, K. W., & Yamamura, H. I. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90679-2 · Cited by 103
Nunnari, J. M., Repaske, M. G., Brandon, S., Cragoe, E. J., & Limbird, L. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45365-3 · Cited by 100
On the Analysis of Pharmacological Experiments in Terms of an Allosteric Receptor Model
Cd, T. (1973) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13687-0 · Cited by 100
Allosteric Modulation of β2-Adrenergic Receptor by Zn2+
Swaminath, G., Steenhuis, J. J., Kobilka, B. K., & Lee, T. W. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.65 · Cited by 99
Nj, B., Farries, T., Gharagozloo, P., Kobayashi, S., Lazareno, S., & Sugimoto, M. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23041-8 · Cited by 94
New approach to drug therapy in Alzheimer's dementia Alfred Maelicke and Edson X. Albuquerque
Maelicke, A., & Albuquerque, E. X. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)89089-1 · Cited by 94
Leppik, R. A., Miller, R. C., Eck, M., & Paquet, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10214-9 · Cited by 92
Gnagey, A. L., Seidenberg, M., & Ellis, J. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1245 · Cited by 91
Modulation of Muscle Nicotinic Acetylcholine Receptors by the Glucocorticoid Hydrocortisone
Bouzat, C., & Barrantes, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.25835 · Cited by 81
Lüllmann, H., Ohnesorge, F. K., Schauwecker, G.-C., & Wassermann, O. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90181-2 · Cited by 79
Gao, Z., van Muijlwijk‐Koezen, J. E., Chen, A., Müller, C. E., IJzerman, A. P., & Jacobson, K. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12515-1 · Cited by 78
Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation
Kostenis, E., & Mohr, K. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10034-1 · Cited by 77
erratum: Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J., Martin, J. R., Bluethmann, H., & Möhler, H. (2000) · Nature · doi:10.1038/35007116 · Cited by 72
Spedding, M., Sweetman, A. J., & Weetman, D. F. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07397.x · Cited by 71
The acetylcholine receptor molecule: allosteric sites and the ion channel
Changeux, J., & Revah, F. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90167-6 · Cited by 69
Inhibition of Lysosomal Plasminogen Activator Activity in Experimental Shock
Tauber, P. F. (2008) · Pharmacology · doi:10.1159/000136361 · Cited by 66
Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors
Hedlund, P. B., Carson, M. J., Sutcliffe, J. G., & Thomas, E. A. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00274-9 · Cited by 60
Ellis, J., & Seidenberg, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1451 · Cited by 59
Buller, S., Zlotos, D. P., Mohr, K., & Ellis, J. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.160 · Cited by 56
Kourounakis, A. P., Visser, C. C., de Groote, M., & IJzerman, A. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00536-0 · Cited by 49
Kenakin, T., & Boselli, C. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22846-4 · Cited by 42
Adenosine A1 Receptor-Dependent and -Independent Effects of the Allosteric Enhancer PD 81,723
Musser, B., Mudumbi, R. V., Liu, J., Olson, R. D., & Vestal, R. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37975-3 · Cited by 40
Leppik, R. A., Mynett, A., Lazareno, S., & Birdsall, N. J. M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26407-5 · Cited by 38
Mennerick, S. J., Zeng, C.-M., Benz, A. M., Shen, W., Izumi, Y., Evers, A. S., Covey, D. F., & Zorumski, C. F. (2001) · PubMed · Cited by 36
Aspirin and Sodium Salicylate Inhibit Endothelin ETA Receptors by an Allosteric Type of Mechanism
Talbodec, A., Berkane, N., Blandin, V., Breittmayer, J. P., Ferrari, É., Frelin, C., & Vigne, P. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.797 · Cited by 34
THE PHARMACOLOGY OF AMINO-ACID RESPONSES IN SEPTAL NEURONS
Kumamoto, E. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00016-6 · Cited by 25
Allosteric interactions and modulator requirement for NMDA receptor function
Marvizón, J. C. G., & Baudry, M. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90083-3 · Cited by 21
Allosteric Inhibition of Endothelin ETA Receptors by 3,5-Dibromosalicylic Acid
Blandin, V., Vigne, P., Breittmayer, J. P., & Frelin, C. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1461 · Cited by 21
Proteins-Paradigms of complex systems
Frauenfelder, H. (1995) · Cellular and Molecular Life Sciences · doi:10.1007/bf01931093 · Cited by 8
Use of a spreadsheet to quantitate the equilibrium binding of an allosteric modulator
Christopoulos, A., & Mitchelson, F. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00476-2 · Cited by 5
Self-citation
Cited by
Wang, X., Shen, Y., Wang, S., Li, S., Zhang, W., Liu, X., Lai, L., Pei, J., & Li, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx374 · Cited by 1,588
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationG Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Self-citationInferring the molecular and phenotypic impact of amino acid variants with MutPred2
Pejaver, V., Urresti, J., Lugo-Martinez, J., Pagel, K. A., Lin, G. N., Nam, H.-J., Mort, M., Cooper, D. N., Sebat, J., Iakoucheva, L. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19669-x · Cited by 923
Metadata
- Authors
- Christopoulos, A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-03-01
- Volume
- 1
- Issue
- 3
- Pages
- 198-210
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2042239308
- Cited by
- 664
- References
- 103
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.